Dr. James Beach brings over eighteen years of experience in imaging systems to CytoViva’s hyperspectral systems development program.  James joined CytoViva in 2008 and led the initial development and deployment of CytoViva’s hyperspectral imaging product offerings.  Now retired, he serves as our science and technology advisor. ​

 

In 2000, Dr. Beach co-founded an ophthalmic imaging company located in Reykjavik, Iceland, which markets a retinal oxygen monitoring camera system based on his original work at the University of Virginia.  He has been involved in the miniaturization of hyperspectral detector systems under NASA-sponsored research programs at the Stennis Space Center and received a Space Foundation Hall of Fame award in 2005 for his contributions to portable hyperspectral imaging systems.  He was awarded NIH-funding for retinal disease research at the University of Virginia and later developed hyperspectral imaging for screening early Alzheimer's disease at the University of Minnesota. ​

​

Dr. Beach earned his bachelor of science degree in electrical engineering in 1971 and master of science degree in bioengineering in 1976, both from the University of Michigan.  He earned his doctoral degree in biomedical engineering from the University of Virginia in 1983.